Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neural Ice for knee osteoarthritis pain
NCT06700109Active, not recruiting
- Sponsor
- Brixton Biosciences
- Start
- Nov 2024
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Randomised trial (2 arms), sponsored by Brixton Biosciences. Primary endpoints: Primary Effectiveness at 3 months and Primary Safety at 6 months. Started Nov 2024; status: active, not recruiting.
Beyond the preview
Go deeper on NCT06700109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06700109.